Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 14, 2022 - Fresenius Kabi announced the FDA approval of Idacio (adalimumab-aacf), a biosimilar to AbbVie’s Humira® (adalimumab).
Download PDF
Return to publications
